CHEMUNG FINANCIAL CORP Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Chemung Financial Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Chemung Financial Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.64M, a 3.64% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.64M -$213K -3.64% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.83M -$223K -3.69% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.02M -$232K -3.71% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.65M -$801K -12.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $5.85M -$796K -12% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.05M -$791K -11.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $6.25M -$785K -11.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $6.45M -$785K -10.9% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $6.65M -$438K -6.18% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $6.84M -$433K -5.95% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $7.04M -$300K -4.09% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $7.23M +$89K +1.25% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $7.08M -$390K -5.22% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $7.27M -$376K -4.92% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $7.34M -$491K -6.27% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $7.15M -$856K -10.7% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $7.47M -$577K -7.17% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $7.65M -$570K -6.93% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $7.83M -$565K -6.73% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $8M +$8M Dec 31, 2019 10-K 2021-03-24
Q3 2019 $8.05M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $8.22M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $8.39M Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.